Libidon – A-16 Prostate Peptide Bioregulator

• What it is: A targeted amino acid/peptide complex (A-16) marketed as a food supplement for prostate tissue support.

• Primary claim: Supports and normalizes prostate epithelial cell function, particularly for aging prostates and mild-to-severe benign prostatic hyperplasia (BPH) symptoms.

• Origin: Russian bioregulator research tradition (Vladimir Khavinson). [1, 2]

Scientific & Clinical Context Libidon – A-16 Prostate Peptide Bioregulator

• Proposed Mechanism: Designed to interact with DNA/chromatin to regulate protein synthesis and cellular regeneration in prostate tissue.

• Evidence Base: Animal/experimental and small-scale clinical observations reported by the St. Petersburg Institute claimed partial or full tissue structure normalization in subset trials of BPH patients. [1]

• Regulatory Status: Regulated as a dietary/food supplement, not an FDA-approved or EMA-approved prescription pharmaceutical. Large-scale, double-blind, placebo-controlled western clinical trials meeting modern drug standards are sparse.

• Allergen/Ingredients Note: Commercial encapsulated versions (e.g., Nature’s Marvels) typically combine the A-16 peptide complex with a rice flour base, HPMC capsule, and potential milk-derived components. Shelf life is generally 3 years. [1]

• Medical Consultation: Required before use if you have diagnosed prostate pathology (such as prostate cancer), take prescription medications, or experience urinary obstruction/red flag symptoms (blood in urine, acute retention). [1]

• Not a Substitute: Should not replace standard medical evaluations, PSA monitoring, or evidence-based treatments for BPH or prostatitis prescribed by a urologist.